piyasalar Perşembe, 23 Nisan 2026 0,00

Roche CEO laments Swiss franc strength as drugmaker doubles down on U.S. investment

Currency effects weighed on the Swiss drugmaker's first-quarter earnings

Roche CEO laments Swiss franc strength as drugmaker doubles down on U.S. investment basliginda one cikan gelisme: Currency effects weighed on the Swiss drugmaker's first-quarter earnings

Fonvera editor notu: Haberin piyasa etkisini izlemek icin ilgili varlik sayfalari ve ekonomik takvim akisi birlikte okunmalidir.

Orijinal kaynak: CNBC

Paylaş: